10.0.3.230

    Paul Capital securitises large part of pharmaceutical royalty fund

    By
    -
    1391
    The notes have been assigned a rating of Aaa by Moody’s and a rating of AAA by Standard and Poor’s. The Pau

    RELATED ARTICLESMORE FROM AUTHOR